ReviewNature reviews. Clinical oncology2018
Epigenome-based cancer risk prediction: rationale, opportunities and challenges.
Martin Widschwendter et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
110 papers cite itlatest 60 shown
this paperpooled ittrialcites it